Clinical significance of cathepsin D in primary ovarian cancer
- 31 December 1994
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 30 (7), 935-940
- https://doi.org/10.1016/0959-8049(94)90118-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Prognostic significance of cathepsin-D in patients with breast cancerBritish Journal of Cancer, 1993
- Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1Journal of Clinical Endocrinology & Metabolism, 1992
- Estradiol increases the secretion by MCF7 cells of several lysosomal pro-enzymesBiochemical and Biophysical Research Communications, 1990
- Cathepsin D and Prognosis in Breast CancerThe New England Journal of Medicine, 1990
- Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical studyCancer, 1990
- Estrogen‐induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?Journal of Cellular Biochemistry, 1987
- The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic proteaseBiochemical and Biophysical Research Communications, 1986
- Autocrine Growth Stimulation of the MCF 7 Breast Cancer Cells by the Estrogen-Regulated 52 K Protein*Endocrinology, 1986
- Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of cathepsin BBiochimica et Biophysica Acta (BBA) - General Subjects, 1983
- Estradiol induced proteins in the MCF7 human breast cancer cell lineBiochemical and Biophysical Research Communications, 1979